These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 36137754)
21. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis. Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788 [TBL] [Abstract][Full Text] [Related]
30. The podocyte as a direct target of immunosuppressive agents. Schönenberger E; Ehrich JH; Haller H; Schiffer M Nephrol Dial Transplant; 2011 Jan; 26(1):18-24. PubMed ID: 20937691 [TBL] [Abstract][Full Text] [Related]
31. The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome. Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H Am J Nephrol; 2000; 20(3):175-9. PubMed ID: 10878397 [TBL] [Abstract][Full Text] [Related]
32. [Nephrotic syndrome in childhood]. Reusz G; Szabó A; Fekete A Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687 [TBL] [Abstract][Full Text] [Related]
33. Focal segmental glomerulosclerosis and proteinuria associated with Myo1E mutations: novel variants and histological phenotype analysis. Krendel M; Leh S; Garone ME; Edwards-Richards A; Lin JJ; Brackman D; Knappskog P; Mikhailov A Pediatr Nephrol; 2023 Feb; 38(2):439-449. PubMed ID: 35723736 [TBL] [Abstract][Full Text] [Related]
34. [Ultrastructural study of podocyte alterations in non proliferative glomerulopathy]. Sipovsky VG; Nevorotin AI; Avsiewitsch IV; Smirnov AV Arkh Patol; 2019; 81(3):51-58. PubMed ID: 31317931 [TBL] [Abstract][Full Text] [Related]
35. A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies. Ye Q; Lan B; Liu H; Persson PB; Lai EY; Mao J Acta Physiol (Oxf); 2022 Aug; 235(4):e13850. PubMed ID: 35716094 [TBL] [Abstract][Full Text] [Related]
37. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease. da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279 [TBL] [Abstract][Full Text] [Related]
38. Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle. Candelier JJ; Lorenzo HK Cell Tissue Res; 2020 Feb; 379(2):231-243. PubMed ID: 31848752 [TBL] [Abstract][Full Text] [Related]
39. [Idiopathic nephrotic syndrome: une Arlésienne?]. Lorenzo HK; Candelier JJ Med Sci (Paris); 2019; 35(8-9):659-666. PubMed ID: 31532378 [TBL] [Abstract][Full Text] [Related]
40. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Barisoni L; Schnaper HW; Kopp JB Clin J Am Soc Nephrol; 2007 May; 2(3):529-42. PubMed ID: 17699461 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]